Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Stoke Therapeutics (NASDAQ:STOK) Announces Quarterly Earnings Results

Summary by MarketBeat
Stoke Therapeutics (NASDAQ:STOK - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($0.93) by ($0.15). Stoke Therapeutics had a negative net margin of 753.60% and a negative return on equity of 59.36%. The firm had revenue of $11.26 million for the quarter, compared to the consensus estimate of $8.21 million.

1 Articles

MarketBeatMarketBeat
Center

Stoke Therapeutics (NASDAQ:STOK) Announces Quarterly Earnings Results

Stoke Therapeutics (NASDAQ:STOK - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($0.93) by ($0.15). Stoke Therapeutics had a negative net margin of 753.60% and a negative return on equity of 59.36%. The firm had revenue of $11.26 million for the quarter, compared to the consensus estimate of $8.21 million.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Needham icon

Needham

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal